Home »

Advanced Catheter Therapies Receives FDA 510(k) Clearance on Occlusion Perfusion Catheter

CHATTANOOGA, TN — (Marketwired) — 10/08/13 — Advanced Catheter Therapies, Inc. (ACT), () today announced that its Occlusion Perfusion Catheter (OPC) has received U.S. Food and Drug Administration (FDA) 510(k) clearance. ACT is a research and development medical device company with a portfolio of innovative catheter technologies initially targeting vascular disease and restenosis."ACT is very excited about the FDA 510(k) approval for the OPC," said Paul J. Fitzpatrick, CEO of ACT. &

Advanced Catheter Therapies Awarded Patent

CHATTANOOGA, TN — (Marketwire) — 01/10/12 — Advanced Catheter Therapies, Inc. (ACT), () today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8088103 for its catheter technology. The company recently announced a name change from Atlanta Catheter Therapies.The patent, entitled "Occlusion Perfusion Catheter," was issued on January 3, 2012. The Occlusion Perfusion Catheter (OPC) is a multi-lumen balloon catheter designed to temporarily occlude

New Name Announced for Atlanta Catheter Therapies

-Advanced Catheter Therapies- Result of Move to Chattanooga

Analytics

© 2020 88Finance. All Rights Reserved. Log in - Copyright by LayerMedia


Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de